tiprankstipranks
Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ:ARTV
US Market
ARTV
Artiva Biotherapeutics, Inc.
RESEARCH TOOLSreports
Want to see ARTV full AI Analyst Report?

Artiva Biotherapeutics, Inc. (ARTV) Income Statement

473 Followers

Artiva Biotherapeutics, Inc. Income Statement

Last quarter (Q1 2026), Artiva Biotherapeutics, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Artiva Biotherapeutics, Inc.'s net income was $-23.52M. See Artiva Biotherapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 251.00K$ 33.49M$ 4.93M$ 2.00M
Gross Profit
$ -2.60M$ 251.00K$ 33.49M$ 4.93M$ 2.00M
Operating Expenses
$ 88.01M$ 67.53M$ 64.16M$ 64.76M$ 55.27M
Depreciation and Amortization
$ 2.60M$ 2.43M$ 2.27M$ 1.16M$ 248.00K
EBITDA
$ -88.01M$ -64.85M$ -28.41M$ -58.67M$ -71.58M
Operating Income
$ -90.61M$ -67.28M$ -30.67M$ -59.83M$ -53.27M
Other Income/Expenses
$ 6.75M$ 8.79M$ 3.05M$ 1.49M$ -18.55M
Pretax Income
$ -83.86M$ -58.49M$ -27.62M$ -58.34M$ -71.83M
Net Income
$ -83.86M$ -58.49M$ -27.70M$ -58.39M$ -71.83M
Per Share Metrics
Basic EPS
$ -3.43$ -5.20$ -1.19$ -3.32$ -4.08
Diluted EPS
$ -3.43$ -5.20$ -1.19$ -3.32$ -4.08
Weighted Average Shares Outstanding
 24.44M 24.36M 23.28M 17.58M 17.58M
Weighted Average Shares Outstanding (Diluted)
 24.44M 24.36M 23.28M 17.58M 17.58M
Currency in USD

Artiva Biotherapeutics, Inc. Earnings and Revenue History